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An effective chemical approach to modulation of biological interactions of cationic polymers was proposed and
tested using polyethyleneimine (PEI) as a drug carrier. Branched 25 kDa PEI was modiﬁed in the reaction with
propylene oxide (PO) to produce a series of propoxylated PEIs with NH groups grafted by single or oligomer
PO units. Clear relationships between the propoxylation degree and biological effects, such as interaction with
plasmid DNA, hemolytic, cytotoxic, and pro-apoptotic activities were revealed for PEIs modiﬁed upon PO/NH
molar ratio of 0.5, 0.75, 1.0 and 3.0. The partial modiﬁcation of available cationic centers up to 100% is predom-
inantly accompanied by a signiﬁcant gradual reduction in polycation adverse effects, while ability of complex
formation with plasmid DNA is being preserved. Grafted PEI with 0.75 PO/NH ratio provides better protection
from nuclease degradation and transfection activity compared with other modiﬁed PEIs. Revealed relationships
contribute to the development of safe polymeric systems with controllable physicochemical properties and
biological interactions.









Synthetic cationic polymers are important polymeric systemswhich
have been intensively studied as components of biomedical materials
and drug formulations. Cationic polymers exhibit relatively strong
interactions with anionic membrane constituents, nucleic acids and
other macromolecules, which may result in beneﬁcial antimicrobial
effect [1,2] and promotion of cellular uptake [3], or undesirable
(cyto-)toxicity [4].
Cationic polymers have been used as cell adhesives [5], controlled
release systems [6,7], and oral drug formulations [8,9]. Non-viral gene
delivery is one of the most promising applications of cationic polymers,
which covers the direct gene therapy of multiple disease, modiﬁcation
of biomedical materials as well as cell biology research [10,11].
Basic amino acids and their derivatives have been utilized to produce
biodegradable linear homopeptides and dendrimeric poly(amidoamine)
peptides with a good ability for binding, condensation and cellular trans-
location of nucleic acids [10–14]. Among synthetic cationic carriers,
polyethylenimines (PEIs) are considered as the ‘gold standard’ character-
ized by a high cationic charge, controllable structure, and robust synthesis
techniques [15,16].
Toxicity issues of PEIs and other polycations have been reported
previously in experimental studies [17–22] and reviews [3,16]. High
membrane-damaging and hemolytic action of the polycations remains
the main obstacle to their use as therapeutic gene carriers [4]. Adverse
effects of cationic polymers are especially critical in vivo, compromising
their therapeutic potential [23].
An appropriate chemical structure of cationic polymers should be
developed to reduce side interactions, toxic outcome and improve
pharmacokinetics of polymeric complexes with a substance delivered.
Grafting of polymer backbone with small molecules and oligomers is a
primary approach to improving biocompatibility of polycations, opti-
mizing their cellular transport, and increasing selectivity. Attachment
of saccharides, e.g. by cross-linking of PEI fragments with mannitol
diacrilate to stimulate caveolae-mediated endocytosis [24], grafting of
PEG molecules [19,25,26], and some combinative modiﬁcations [11,
27] were recently proposed. Labeling of biodegradable PEI derivative
with pyridoxal phosphate for speciﬁc gene delivery into cancer cells
was reported [28]. Similarly, PEI–pullulan–folic acid conjugate has
been recently developed for targeted delivery of plasmid DNA and
short interfering RNA into folate receptor-overexpressing cells [29].
Among above approaches, PEGylation is the most accepted technol-
ogy to modulate bio-interactions of macromolecular drugs and poly-
mers [15,20,26,30]. In particular, structure-activity relationships of PEI
modiﬁed with different PEG molecules of ~0.5–20 kDa were examined
in [19,25]. The PEGylation allows for non-speciﬁc attenuation of side
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